Eisai
4523.T
#2235
Rank
NZ$15.12 B
Marketcap
NZ$53.58
Share price
0.38%
Change (1 day)
-9.86%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.51. In 2026 the company made an earnings per share (EPS) of NZ$1.50 a decrease over its 2025 EPS that were of NZ$1.90.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026NZ$1.50-21.04%
2025NZ$1.9011.85%
2024NZ$1.70-32.63%
2023NZ$2.525.52%
2022NZ$2.39-74.01%
2021NZ$9.18-66.58%
2020NZ$27.4898.24%
2019NZ$13.8617.01%
2018NZ$11.8437.78%
2017NZ$8.60-27.62%
2016NZ$11.8835.33%
2015NZ$8.78-2.82%
2014NZ$9.03-27.66%
2013NZ$12.49-27.49%
2012NZ$17.22-12.67%
2011NZ$19.7288.08%
2010NZ$10.48-11.06%
2009NZ$11.79-390.15%
2008NZ-$4.06-127.78%
2007NZ$14.63347.11%
2006NZ$3.274.38%
2005NZ$3.137.4%
2004NZ$2.9243.03%
2003NZ$2.0425.09%
2002NZ$1.6352.67%
2001NZ$1.0769.76%
2000NZ$0.63